ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1135

IL-34/PTP-ζ Axis on Macrophages Promotes Renal Fibrosis in Mice with Unilateral Ureteral Obstruction

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Abe, Tetsuya, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Wada, Yukihiro, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Takeuchi, Emiko, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Okawa, Hiroyuki, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Satoh, Masashi, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Imanishi, Takayuki, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Suenaga, Tadahiro, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
  • Takeuchi, Yasuo, Kitasato Daigaku Igakubu, Sagamihara, Kanagawa Prefecture, Japan
Background

Previously, we have demonstrated the intrarenal upregulation of protein-tyrosine phosphatase ζ receptor (PTP-ζ), the second receptor for interleukin (IL)-34 for macrophages (Mø) proliferation, in mice with unilateral ureteral obstruction (UUO). However, the specific site of PTP-ζ expression in UUO kidneys and the role of IL-34/PTP-ζ axis in renal fibrosis remain elusive.

Methods

10-week-old male wild-type (WT) C57BL/6 (B6) mice (n = 14) and age-matched PTP-ζ knockout (KO) B6 mice (n = 16) were induced UUO. All mice were sacrificed on day 14. In vitro, mouse bone marrow-derived macrophages (BMMø) were isolated for analysis.

Results

Compared to sham ope mice, the UUO kidneys of WT mice exhibited severe renal fibrosis with significant intrarenal expressions of IL-34 and PTP-ζ. In the KO mice, the sirius-red+ area in UUO kidneys, was significantly reduced compared to WT mice (Fig A, B), despite comparable intrarenal IL-34 expressions. The intrarenal mRNA levels of TGF-β were lower in KO mice. IF analysis revealed that KO mice showed significantly fewer F4/80+ Mø and α-SMA+ myofibroblasts in UUO kidneys, along with lower levels of intrarenal transcripts for Chil3 and Timp-1. FACS analysis showed that the ratio of CD11c-CD206+ cells within intrarenal CD11b+F4/80+ Mø population was higher in KO mice. In vitro, western blotting confirmed PTP-ζ expressions in BMMøs from WT mice after TGF-β (5 ng/mL) stimulation (Fig C). Stimulation with TGF-β and recombinant IL (rIL)-4 (20 ng/mL) significantly increased Arginase 1 transcripts in WT-BMMøs, with further amplification upon treatment with rIL-34 (5 ng/mL). In contrast, rIL-34 treatment did not enhance Arginase 1 mRNA levels in KO-BMMøs mice after TGF-β and rIL-4 stimulation.

Conclusion

IL-34 binding to PTP-ζ on Mø proliferate M2-like Mø in UUO kidneys, promoting renal fibrosis by enhancing profibrotic response and accumulating myofibroblasts. Thus, IL-34/PTP-ζ axis on Mø might represent a therapeutic target for renal fibrosis.

Digital Object Identifier (DOI)